BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Price M, Monteiro AN. Fine tuning chemotherapy to match BRCA1 status. Biochem Pharmacol 2010;80:647-53. [PMID: 20510205 DOI: 10.1016/j.bcp.2010.05.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Atipairin A, Ratanaphan A. In Vitro Enhanced Sensitivity to Cisplatin in D67Y BRCA1 RING Domain Protein. Breast Cancer (Auckl) 2011;5:201-8. [PMID: 22084573 DOI: 10.4137/BCBCR.S8184] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
2 Dever SM, White ER, Hartman MC, Valerie K. BRCA1-directed, enhanced and aberrant homologous recombination: mechanism and potential treatment strategies. Cell Cycle 2012;11:687-94. [PMID: 22306997 DOI: 10.4161/cc.11.4.19212] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
3 O'Byrne KJ, Barr MP, Gray SG. The role of epigenetics in resistance to Cisplatin chemotherapy in lung cancer. Cancers (Basel) 2011;3:1426-53. [PMID: 24212667 DOI: 10.3390/cancers3011426] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
4 Cho WCS. Conquering cancer through discovery research. IUBMB Life 2010;62:655-9. [DOI: 10.1002/iub.369] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
5 Atipairin A, Canyuk B, Ratanaphan A. The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by the platinum-based anticancer drugs. Breast Cancer Res Treat 2011;126:203-9. [PMID: 20878461 DOI: 10.1007/s10549-010-1182-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
6 Cho EJ, Kim JK, Baek HJ, Kim SE, Park EJ, Choi BK, Kim TH, Shin DH, Lim YK, Deng CX, Kim SS. Preclinical evaluation of radiation therapy of BRCA1-associated mammary tumors using a mouse model. Int J Biol Sci 2021;17:689-701. [PMID: 33767581 DOI: 10.7150/ijbs.53667] [Reference Citation Analysis]
7 Rass E, Grabarz A, Bertrand P, Lopez BS. [Double strand break repair, one mechanism can hide another: alternative non-homologous end joining]. Cancer Radiother 2012;16:1-10. [PMID: 21737335 DOI: 10.1016/j.canrad.2011.05.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
8 Narod SA. BRCA mutations in the management of breast cancer: the state of the art. Nat Rev Clin Oncol 2010;7:702-7. [DOI: 10.1038/nrclinonc.2010.166] [Cited by in Crossref: 105] [Cited by in F6Publishing: 100] [Article Influence: 9.5] [Reference Citation Analysis]
9 Hengel SR, Spies MA, Spies M. Small-Molecule Inhibitors Targeting DNA Repair and DNA Repair Deficiency in Research and Cancer Therapy. Cell Chem Biol 2017;24:1101-19. [PMID: 28938088 DOI: 10.1016/j.chembiol.2017.08.027] [Cited by in Crossref: 65] [Cited by in F6Publishing: 63] [Article Influence: 16.3] [Reference Citation Analysis]